Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual

Journal of Immunology

Volumn 161, Issue 9, 1998, Pages 4875-4881

  Harrer, Thomas ^a,b   Harrer, Ellen ^a,b   Barbosa, Peter ^c,g   Kaufmann, Friedemann ^e   Wagner, Ralf ^e   Brüggemann, Susanne ^a   Kalden, Joachim R ^a   Feinberg, Mark ^c,d   Johnson, R Paul ^b   Buchbinder, Susan ^f   Walker, Bruce D ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c GLADSTONE INSTITUTES   (United States)

^d Center for AIDS Research   (United States)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f AIDS Office San Francisco   (United States)

^g California College of Pediatric Medicine San Francisco Campus   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; EPITOPE; INTERLEUKIN 2; MONOCLONAL ANTIBODY; SYNTHETIC PEPTIDE;

ANIMAL CELL; ARTICLE; CASE REPORT; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENIC VARIATION; CD4 LYMPHOCYTE COUNT; COS CELLS; DISEASE PROGRESSION; EPITOPES; GENE PRODUCTS, GAG; HIV ANTIGENS; HIV LONG-TERM SURVIVORS; HIV-1; HLA-A ANTIGENS; HLA-A2 ANTIGEN; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROVIRUSES; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; VIRAL LOAD; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0032211068     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Reddehase, M., F. Weiland, K. Muench, S. Jonjic, A. Lueske, and U. Koszinowski. 1985. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infections of the lungs. J. Virol. 55:264.
2. Walter, W. A., P. D. Greenberg, M. J. Gilbert, R. J. Finch, K. S. Watanabe, E. D. Thomas, and S. R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1038.
3. Walker, B. D., S. Chakrabarti, B. Moss, T. Paradis, T. Flynn, A. Durno, R. S. Blumberg, J. C. Kaplan, M. S. Hirsch, and T. T. Schooley, 1987. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:345.
4. Nixon, D. F., A. R. Townsend, J. G. Elvin, C. R. Rizza, J. Gallwey, and A. J. McMichael. 1988. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336:484.
5. Koenig, S., P. Earl, D. Powell, G. Pantaleo, S. Merli, B. Moss, and A. S. Fauci. 1988. Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual. Proc. Natl. Acad. Sci. USA 85:8638.
6. Koup, R. A., J. L. Sullivan, P. H. Levine, D. Brettler, A. Mahr, G. Mazzara, S. McKenzie, and D. Panicali. 1989. Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. Blood 73:1909.
7. Plata, F., B. Autran, and L. Martins. 1987. AIDS virus-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:348.
8. Riviere, Y., S. Tanneau, and A. Regnault. 1989. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. J. Virol. 63:2270.
9. Koup, R. A., J. T. Safrit, Y. Cao, A. Andrews, G. McCloud, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune response with the initial control of viremia in primary HIV-1 syndrome. J. Virol. 68:4650.
10. Borrow, P., H. Lewicki, X. Wei, M. S. Horwitz, N. Peffer, H. Meyers, J. A. Nelson, J. E. Gairin, B. H. Hahn, M. B. A. Oldstone, and G. M. Shaw. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T-lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3:205.
11. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103.
12. Pantaleo, G., J. F. Demarest, T. Schacker, M. Vaccarezza, O. J. Cohen, M. Daucher, C. Graziosi, S. S. Schnittman, T. C. Quinn, G. M. Shaw et al. 1997. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc. Natl Acad. Sci. USA 94:254.
13. Musey, L., J. Hughes, T. Schacker, T. Shea, C. Lawrence, and M. J. McElrath. 1997. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 337:1267.
14. Harrer, E., T. Harrer, S. Buchbinder, D. L. Mann, M. Feinberg, T. Yilma, R. P. Johnson, and B. D. Walker. 1994. HIV-1-specific cytotoxic T lymphocyte response in healthy long-term nonprogressing seropositive persons. AIDS Res. Hum. Retroviruses 10:S77.
15. + lymphocyte activity. J. Infect. Dis. 172:329.
16. Harrer, T., E. Harrer, S. A. Kalams, T. Elbeik, M. Feinberg, Y. Cao, D. D. Ho, T. Yilma, A. M. Caliendo, R. P. Johnson, S. Buchbinder, and B. D. Walker. 1996. Strong cytotoxic T cells and weak neutralizing antibody responses in a subset of persons with stable non-progressing HIV-1 infection. AIDS Res. Hum. Retroviruses 12:585.
17. Klein, M. R., C. A. van Baalen, A. M. Holwerda, S. R. Kerkhof Garde, R. J. Bende, I. P. M. Keet, J. K. M. Eeftinck-Schattenkerk, A. D. M. E. Osterhaus, H. Schuitemaker, and F. Miedema. 1996. Kinetics of Gag-specific cytotoxic T-lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1365.
18. Goulder, P. J. R., R. E. Phillips, R. A. Colbert, S. McAdam, G. Ogg, M. A. Nowak, P. Giangrande, G. Luzzi, B. Borgan, A. Edwards, A. J. McMichael, and S. Rowland-Jones. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3:212.
19. Rinaldo, C., X. L. Huang, Z. F. Fan, M. Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottril et al. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-I-infected long-term nonprogressors. J. Virol. 69:5838.
20. Rötschke, O., K. Falk, K. Deres, H. Schild, M. Norda, J. Metzger, G. Jung, and H.-G. Rammensee. 1990. Isolation and analysis of naturally processed peptides as recognized by cytotoxic T cells. Nature 348:252.
21. + cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication. Adv. Immunol. 66:273.
22. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117.
23. + A24-restricted cytotoxic T lymphocytes. J. Virol. 66:3151.
24. Phillips, R. E., S. Rowland-Jones, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. M. Bangham, C. R. Rizza, and A. J. McMichael. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354:453.
25. Koenig, S., A. J. Conley, Y. A. Brewah, G. M. Jones, S. Leath, L. J. Boots, V. Davey, G. Pantaleo, J. F. Demarest, C. Carter, C. Wannebo, J. R. Yannelli, S. A. Rosenberg, and H. C. Lane. 1995. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat. Med. 1:330.
26. Nowak, M., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Lalloo, S. M. McAdam, P. Klenerman, B. Koeppe, K. Sigmund, C. R. M. Bangham, and A. J. McMichael. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606.
27. Kalams, S. A., R. A. Johnson, M. J. Dynan, K. E. Harmant, T. Harrer, E. Harrer, A. K. Troca, S. Buchbinder, and B. D. Walker. 1996. T cell receptor (TCR) usage and fine specificity of HIV-1-specific cytotoxic T lymphocyte (CTL) clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant. J. Exp. Med. 183:1669.
28. Wilson, C. C., S. A. Kalams, B. M. Wilkes, D. J. Ruhl, F. Gao, B. H. Hahn, I. C. Hanson, K. Luzuriaga, S. Wolinsky, R. Koup, S. P. Buchbinder, R. P. Johnson, and B. D. Walker. 1997. Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition. J. Virol. 71:1256.
29. Harrer, T., E. Harrer, S. A. Kalams, P. Barbosa, A. Trocha, R. P. Johnson, T. Elbeik, M. Feinberg, S. Buchbinder, and B. D. Walker. 1996. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection: breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J. Immunol. 156:2616.
30. Walker, B. D., C. Flexner, T. J. Paradis, T. C. Fuller, M. S. Hirsch, R. T. Schooley, and B. Moss. 1988. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 240:64.
31. + population. Science 260:99.
32. Koup, R. A., J. L. Sullivan, P. H. Levine, F. Brewster, A. Mahr, G. Mazzara, S. McKenzie, and D. Panicali. 1989. Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody positive sera. J. Virol. 63:584.
33. Johnson, R. P., A. Trocha, L. Yang, G. P. Mazzara, D. L. Panicali, T. M. Buchanan, and B. D. Walker. 1991. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes: fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J. Immunol. 147:1512.
34. + T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. Proc. Natl. Acad. Sci. USA 88:11276.
35. Wong, J., and R. Colvin. 1987. Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens. J. Immunol. 139:1369.
36. Walker, B. D., C. Flexner, K. Birch-Limberger, L. Fisher, T. J. Paradis, A. Aldovini, R. Young, B. Moss, and R. T. Schooley. 1989. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type. Proc. Natl. Acatl. Sci. USA 86:9514.
37. Hollinger, F. B., J. W. Bremer, L. E. Myers, J. W. Gold, and L. McQuay. 1992. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group: The NIH/NIAID/DAIDS/ACTG Virology Laboratories. J. Clin. Microbiol. 30:1787.
38. Piatak, M. J., K. C. Luk, B. Williams, and J. D. Lifson. 1993. Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques 14:70.
39. Wagner, R., T. Boltz, L. Demi, S. Modrow, and H. Wolf. 1993. Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3chimeric vaccinia viruses. J Gen. Virol. 74:1261.
40. Lubaki, N. M., S. C. Ray, B. Dhruva, T. C. Quinn, R. F. Siliciano, and R. C. Bollinger. 1997. Characterization of a polyclonal cytolytic T lymphocyte response to human immunodeficiency virus in persons without clinical progression. J. Infect. Dis. 175:1360.
41. Wasik, T. J., P. P. Jagodzinski, E. M. Hyjek. J. Wustner, G. Trinchieri, H. W. Lischner, and D. Kozbor. 1997. Diminished HIV-specific CTL activity is associated with lower type 1 and enhanced type 2 responses to HIV-specific peptides during perinatal HIV infection. J. Immunol. 158:6029.
42. Wagner, R., H. Fliessbach, G. Wanner, M. Motz, M. Niedrig, G. Deby, A. Von Brundd, and H. Wolf. 1992. Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine. Arch. Virol. 127:117.
43. Buchbinder, S. P., M. H. Katz, N. A. Hessol, P. M. O'Malley, and S. D. Holmberg. 1994. Long-term HIV-1 infection without immunologic progression. AIDS 8:1123.
44. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H. Rammensee. 1991. Allelespecific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
45. Tsomides, T. J., A. Aldovini, R. P. Johnson, B. D. Walker, R. A. Young, and H. N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180:1283.
46. Rainer, L., W. Haseltine, R. Patarca, K. J. Livak, B. Starcich, S. F. Josephs, E. R. Doran, J. A. Rafalsky, E. A. Whitehorn, K. Baumeister et al. 1985. Complete nucleotide sequence of the AIDS virus HTLV-III. Nature 313:277.
47. Stevanovic, S., and H.-G. Rammensee. 1994. Identification of T-cell epitopes using allele-specific ligand motifs. Behring Inst. Mitt. 95:7.
48. Myers, G., J. A. Berzofsky, B. Kober, R. F. Smith, and G. N. Paolakis. 1992. Human retroviruses and AIDS 1992: a compilation and analysis of nucleic acid and amino acid sequences. In Theoretical Biology and Biophysics. Los Alamose National Laboratory, Los Alamos, NM.
49. Freed, E. O., J. M. Orenstein, A. J. Buckler-White, and M. A. Martin. 1994. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68:5311.
50. Goulder, P. J., A. K. Sewell, D. G. Lalloo, D. A. Price, J. A. Whelan, J. Evans, G. P. Taylor, G. Luzzi, P. Giangrande, R. E. Phillips, and A. J. McMichael. 1997. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA): identical siblings with HLA-A*0201 are influenced by epitope mutation. J. Exp. Med. 185:1423.
51. Madden, D. R., D. N. Garboczi, and D. C. Wiley. 1993. The antigenic identity of peptide/MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75:693.
52. Gavioli, R., M. G. Kurilla, P. O. Di Campos-Lima, L. E. Wallace, R. Dolcetti, R. Murray, A. B. Rickinson, and M. G. Masucci. 1993. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J. Virol. 67:1572.
53. Matsumura, M., D. H. Fremont, P. A. Peterson, and I. A. Wilson. 1992. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257:927.
54. Rotzschke, O., K. Falk, and K. Deres. 1990. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348:252.
55. Ossendorp, F., M. Eggers, A. Neisig, T. Ruppert, M. Groettrup, A. Sijts, E. Mengede, P. M. Kloetzel, J. Neefjes, U. Koszinowski, and C. Melief. 1996. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 5:115.
56. Del Val, M., H. J. Schlicht, T. Ruppert, M. J. Reddehase, and U. H. Koszinowski. 1991. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66: 1145.
57. Zweerink, H. J., M. C. Gammon, U. Utz, S. Y. Sauma, T. Harrer, J. C. Hawkins, R. P. Johnson, A. Sirotina, J. D. Hermes, B. D. Walker, and W. E. Biddison. 1993. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. J. Immunol. 150:1763.
58. Bauer, M., M. Lucchiari-Hartz, R. Maier, G. Haas, B. Autran, K. Eichmann, R. Frank, B. Maier, and A. Meyerhans. 1997. Structural constraints of HIV-1 Nef may curtail escape from HLA-B7-restricted CTL recognition. Immunol. Lett. 55: 119.
59. Harrer, E., T. Harrer, P. Barbosa, M. Feinberg, D. Mann, T. Yilma, R. P. Johnson, and B. D. Walker. 1996. Recognition of the highly conserved YMDD region in the HIV-1 reverse transcriptase by HLA A2 restricted CTL from an asymptomatic non-progressing individual. J. Infect. Dis. 173:476.